Compile Data Set for Download or QSAR
Report error Found 19 Enz. Inhib. hit(s) with all data for entry = 13483
TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 798199BDBM798199(US20260078095, Compound Lu-(IIIa) | US20260078095,...)
Affinity DataIC50: 0.590nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 798193BDBM798193(US20260078095, Compound In-(IIIa) | US20260078095,...)
Affinity DataIC50: 0.760nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 798188BDBM798188(US20260078095, Compound (III) | US20260078095, Exa...)
Affinity DataIC50: 0.870nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 798252BDBM798252(US20260078095, Compound Ga-(IIId) | US20260078095,...)
Affinity DataIC50: 0.940nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 798194BDBM798194(US20260078095, Compound Ga-(IIIa) | US20260078095,...)
Affinity DataIC50: 1nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 798196BDBM798196(US20260078095, Compound Y-(IIIa) | US20260078095, ...)
Affinity DataIC50: 1.20nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 798259BDBM798259(US20260078095, Compound In-(Va) | US20260078095, E...)
Affinity DataIC50: 1.30nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 798249BDBM798249(US20260078095, Compound Lu-(IIIb) | US20260078095,...)
Affinity DataIC50: 1.60nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 798255BDBM798255(US20260078095, Compound Zr-(IIIf) | US20260078095,...)
Affinity DataIC50: 2.10nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 798256BDBM798256(US20260078095, Compound (IIIg) | US20260078095, Ex...)
Affinity DataIC50: 2.30nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 798260BDBM798260(US20260078095, Compound (Vb) | US20260078095, Exam...)
Affinity DataIC50: 2.40nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 466500BDBM466500(US10799605, Example 5 | US20240287046, Compound C-...)
Affinity DataIC50: 2.90nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 466502BDBM466502(US10799605, Example 13 | US20260078095, Example 13)
Affinity DataIC50: 3nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 466505BDBM466505(US10799605, Example 19 | US20260078095, Example 19)
Affinity DataIC50: 3.40nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 798251BDBM798251(US20260078095, Compound (IIId) | US20260078095, Ex...)
Affinity DataIC50: 3.70nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 466501BDBM466501(US10799605, Example 12 | US20260078095, Example 12)
Affinity DataIC50: 4.90nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 798232BDBM798232(US20260078095, Compound (IIIb) | US20260078095, Ex...)
Affinity DataIC50: 5.20nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 466504BDBM466504(US10799605, Example 18 | US20260078095, Example 18)
Affinity DataIC50: 5.30nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent

TargetNeurotensin receptor type 1(Human)
3B Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 798250BDBM798250(US20260078095, Compound (IIIc) | US20260078095, Ex...)
Affinity DataIC50: 5.70nMAssay Description:CHO-K1 cells expressing Ga16 and hGPR120 were dispensed into each well of a 96-well plate (3×104 cells/100 μl/well) and then incubated in 5% CO2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/29/2026
Entry Details
US Patent